Ameritas Investment Partners’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Ameritas Investment Partners’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,571	Closed	-$45.3K	–	3039
2022 Q4	$45.3K	Hold	1,571	–	–	﹤0.01%	2127
2022 Q3	$51K	Buy	1,571 +671	+75%	+$19K	﹤0.01%	1972
2022 Q2	$16K	Hold	900	–	–	﹤0.01%	2669
2022 Q1	$16K	Buy	+900	New	+$18.5K	﹤0.01%	2657

Ameritas Investment Partners's CINC Position: Q1 2023 in Review

Ameritas Investment Partners sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 1,571 shares — an estimated $45.3K sold.

Ameritas Investment Partners first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $51K in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Ameritas Investment Partners reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Ameritas Investment Partners sold 1,571 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $45.3K.
Ameritas Investment Partners first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Ameritas Investment Partners's CinCor Pharma, Inc. Common Stock position peaked at $51K in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Ameritas Investment Partners's 13F filing for Q1 2023, filed 10 May 2023.